Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company Read More
Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund up to 75% of 5-Year Costs Read More
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences Read More
